These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6312951)

  • 1. The effect on adrenal axis function of topically applied betamethasone valerate ointment 0.1%.
    Fischer GO
    Australas J Dermatol; 1983 Apr; 24(1):26-32. PubMed ID: 6312951
    [No Abstract]   [Full Text] [Related]  

  • 2. Onset of the vasoconstrictor effect of diflucortolone valerate, betamethasone valerate, and fluocinolone acetonide ointments applied for varying periods under occlusive dressings.
    Szadurski J; Renz F; Gasser D
    Dermatologica; 1976; 153(4):236-42. PubMed ID: 1017533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of the base on the results of clinical trials with topical corticosteroids.
    Vollum DI; Sparkes CG
    Dermatologica; 1979; 158(4):293-8. PubMed ID: 372027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic effects of topical application of beclomethasone 17,21-dipropionate: comparative studies with betamethasone 17-valerate ointment and fluocinonide cream.
    Shimao S
    J Dermatol; 1979 Dec; 6(6):383-90. PubMed ID: 396316
    [No Abstract]   [Full Text] [Related]  

  • 5. Once daily application of diflorasone diacetate ointment compared with betamethasone valerate ointment twice daily in patients with eczematous dermatoses.
    Hersle K; Mobacken H
    J Int Med Res; 1982; 10(6):423-5. PubMed ID: 7152081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pituitary adrenal axis activity during topical treatment with 0,075 g% triamcinolone benetonide cream (author's transl)].
    Meynadier J; Guillot B
    Dermatologica; 1982 May; 164(5):327-30. PubMed ID: 6284561
    [No Abstract]   [Full Text] [Related]  

  • 7. Measuring adrenal function in out-patients using topical corticosteroids.
    Sparkes CG
    Br J Dermatol; 1976 Mar; 94 suppl 12():77-82. PubMed ID: 1268080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cortisol levels in normal volunteers receiving either betamethasone valerate or desoximetasone by topical application.
    Bromley PA; Müller FO; Malan J; Torres J; Vanderbeke O
    S Afr Med J; 1978 Aug; 54(6):239-41. PubMed ID: 362568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical trial comparing hydrocortisone 17-butyrate to betamethasone 17-valerate in a series of patients with eczematous skin diseases.
    Thormann J; Brodthagen H
    Dermatologica; 1976; 152 Suppl 1():209-14. PubMed ID: 782955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-month controlled study of effect of desoximetasone and betamethasone 17-valerate on the pituitary-adrenal axis.
    Cornell RC; Stoughton RB
    Br J Dermatol; 1981 Jul; 105(1):91-5. PubMed ID: 7259982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Fingertip unit" in dermatology.
    Finlay AY; Edwards PH; Harding KG
    Lancet; 1989 Jul; 2(8655):155. PubMed ID: 2567912
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of serial dilution of betamethasone-17-valerate on blanching potential and chemical stability.
    Ryatt KS; Cotterill JA; Mehta A
    J Clin Hosp Pharm; 1983 Jun; 8(2):143-5. PubMed ID: 6875011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind comparison of 1% hydrocortisone plus 10% urea ('Alphaderm') and 0.1% betamethasone 17-valerate in the treatment of non-infective inflammatory dermatoses.
    Khan SA; Williamson DM
    Curr Med Res Opin; 1977-1978; 5(4):354-8. PubMed ID: 343995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of once a day diflorasone diacetate and twice a day betamethasone valerate ointment applications in eczematous dermatitis.
    Johansson EA; Stiger TR
    Curr Med Res Opin; 1984; 9(4):259-64. PubMed ID: 6510015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic effects of 0.064% betamethasone dipropionate ointment and cream by simple application - with emphasis upon the suppression of adrenocortical functions.
    Aso M; Shimao S
    J Dermatol; 1983 Feb; 10(1):55-62. PubMed ID: 6345622
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the pituitary-adrenal axis function in patients on topical steroid therapy.
    Kerner M; Ishay A; Ziv M; Rozenman D; Luboshitzky R
    J Am Acad Dermatol; 2011 Jul; 65(1):215-6. PubMed ID: 21679823
    [No Abstract]   [Full Text] [Related]  

  • 17. A double-blind comparison of 0.25% and 0.05% desoxymethasone, 0.1% betamethasone valerate and 1% hydrocortisone creams in the treatment of eczema.
    Ashton RE; Catterall M; Morley N; Fairris G; Joseph DN
    J Int Med Res; 1987; 15(3):160-6. PubMed ID: 3301455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical comparison of halcinonide and betamethasone valerate in common dermatoses.
    Turnbull BC
    Australas J Dermatol; 1975 Apr; 16(1):17-9. PubMed ID: 1108858
    [No Abstract]   [Full Text] [Related]  

  • 19. The stability and blanching efficacy of betamethasone-17-valerate in emulsifying ointment.
    Ryatt KS; Feather JW; Mehta A; Dawson JB; Cotterill JA; Swallow R
    Br J Dermatol; 1982 Jul; 107(1):71-6. PubMed ID: 7104209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of topical steroid application on natural killer cell activity.
    Lesko MJ; Lever RS; Mackie RM; Parrott DM
    Clin Exp Allergy; 1989 Nov; 19(6):633-6. PubMed ID: 2598103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.